← Braidwell portfolio
13F-HR filing
VALIDATEDHoldings period 2023-03-31 · Filed 2023-05-15 · Accession 0000905148-23-000454
Open official SEC source ↗| # | Issuer | Class / CUSIP | Kind | Shares | Value |
|---|---|---|---|---|---|
| 1 | ACLARIS THERAPEUTICS INC | COM · 00461U105 | LONG | 3,269,094 | $26.4 million |
| 2 | ADAPTIVE BIOTECHNOLOGIES COR | COM · 00650F109 | LONG | 648,451 | $5.7 million |
| 3 | ALECTOR INC | COM · 014442107 | LONG | 3,206,315 | $19.8 million |
| 4 | ALIGN TECHNOLOGY INC | COM · 016255101 | LONG | 207,130 | $69.2 million |
| 5 | ALPHATEC HLDGS INC | NOTE 0.750% 8/0 · 02081GAB8 | LONG | 101,250,000 | $108.2 million |
| 6 | ALX ONCOLOGY HLDGS INC | COM · 00166B105 | LONG | 1,249,900 | $5.6 million |
| 7 | AMGEN INC | COM · 031162100 | LONG | 161,500 | $39.0 million |
| 8 | AMYRIS INC | NOTE 1.500%11/1 · 03236MAJ0 | LONG | 137,850,000 | $39.1 million |
| 9 | ANAPTYSBIO INC | COM · 032724106 | LONG | 973,073 | $21.2 million |
| 10 | ARCELLX INC | COMMON STOCK · 03940C100 | LONG | 333,800 | $10.3 million |
| 11 | ARGENX SE | SPONSORED ADR · 04016X101 | LONG | 24,600 | $9.2 million |
| 12 | AVALO THERAPEUTICS INC | COM NEW · 05338F207 | LONG | 247,254 | $432,695 |
| 13 | AXONICS INC | COM · 05465P101 | LONG | 166,704 | $9.1 million |
| 14 | BELLUS HEALTH INC NEW | COM NEW · 07987C204 | LONG | 4,126,194 | $29.7 million |
| 15 | BIOCRYST PHARMACEUTICALS INC | COM · 09058V103 | LONG | 1,945,134 | $16.2 million |
| 16 | BIOGEN INC | COM · 09062X103 | LONG | 220,742 | $61.4 million |
| 17 | BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 · 10806XAD4 | LONG | 42,294,000 | $27.4 million |
| 18 | BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 · 10806XAB8 | LONG | 143,338,000 | $106.2 million |
| 19 | COMPASS THERAPEUTICS INC | COM · 20454B104 | LONG | 3,247,847 | $10.6 million |
| 20 | CRINETICS PHARMACEUTICALS IN | COM · 22663K107 | LONG | 2,019,714 | $32.4 million |
| 21 | DAY ONE BIOPHARMACEUTICALS I | COM · 23954D109 | LONG | 3,159,895 | $42.2 million |
| 22 | DBV TECHNOLOGIES S A | SPONSORED ADR · 23306J101 | LONG | 12,107,785 | $20.5 million |
| 23 | DECIPHERA PHARMACEUTICALS IN | COM · 24344T101 | LONG | 3,241,351 | $50.1 million |
| 24 | DICE THERAPEUTICS INC | COM · 23345J104 | LONG | 984,800 | $28.2 million |
| 25 | DYNE THERAPEUTICS INC | COM · 26818M108 | LONG | 1,377,872 | $15.9 million |
| 26 | ENANTA PHARMACEUTICALS INC | COM · 29251M106 | LONG | 1,038,310 | $42.0 million |
| 27 | ESPERION THERAPEUTICS INC NE | COM · 29664W105 | LONG | 1,211,519 | $1.9 million |
| 28 | EXACT SCIENCES CORP | NOTE 0.375% 3/0 · 30063PAC9 | LONG | 139,000,000 | $122.7 million |
| 29 | EXACT SCIENCES CORP | NOTE 0.375% 3/1 · 30063PAB1 | LONG | 48,300,000 | $45.2 million |
| 30 | GLAUKOS CORP | COM · 377322102 | LONG | 1,806,651 | $90.5 million |
| 31 | GLOBUS MED INC | CL A · 379577208 | LONG | 335,200 | $19.0 million |
| 32 | GUARDANT HEALTH INC | NOTE 11/1 · 40131MAB5 | LONG | 250,022,000 | $168.8 million |
| 33 | HARROW INC | COM · 415858109 | LONG | 1,452,538 | $30.7 million |
| 34 | HILLEVAX INC | COM · 43157M102 | LONG | 1,620,216 | $26.8 million |
| 35 | ILLUMINA INC | NOTE 8/1 · 452327AK5 | LONG | 11,100,000 | $1.1 million |
| 36 | IMMATICS N.V | SHS · N44445109 | LONG | 322,287 | $2.2 million |
| 37 | IMMUNOCORE HLDGS PLC | ADS · 45258D105 | LONG | 426,110 | $21.1 million |
| 38 | INSMED INC | NOTE 0.750% 6/0 · 457669AB5 | LONG | 3,500,000 | $2.7 million |
| 39 | INSMED INC | NOTE 1.750% 1/1 · 457669AA7 | LONG | 39,963,000 | $36.5 million |
| 40 | INTUITIVE SURGICAL INC | COM NEW · 46120E602 | LONG | 223,120 | $57.0 million |
| 41 | INVITAE CORP | NOTE 2.000% 9/0 · 46185LAB9 | LONG | 16,781,000 | $14.8 million |
| 42 | IONIS PHARMACEUTICALS INC | NOTE 0.125%12/1 · 462222AB6 | LONG | 36,533,000 | $33.8 million |
| 43 | IONIS PHARMACEUTICALS INC | NOTE 4/0 · 462222AD2 | LONG | 52,740,000 | $48.1 million |
| 44 | IRHYTHM HOLDINGS INC | COM · 450056106 | LONG | 454,169 | $56.3 million |
| 45 | IVERIC BIO INC | COM · 46583P102 | LONG | 3,714,672 | $90.4 million |
| 46 | KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 · 48576UAA4 | LONG | 65,976,000 | $51.1 million |
| 47 | KRYSTAL BIOTECH INC | COM · 501147102 | LONG | 348,036 | $27.9 million |
| 48 | LEGEND BIOTECH CORP | SPONSORED ADS · 52490G102 | LONG | 601,801 | $29.0 million |
| 49 | MERSANA THERAPEUTICS INC | COM · 59045L106 | LONG | 3,355,805 | $13.8 million |
| 50 | MERUS N V | COM · N5749R100 | LONG | 1,473,084 | $27.1 million |
| 51 | MINERALYS THERAPEUTICS INC | COM · 603170101 | LONG | 550,300 | $8.6 million |
| 52 | MIRATI THERAPEUTICS INC | COM · 60468T105 | LONG | 452,000 | $16.8 million |
| 53 | NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 · 63009RAD1 | LONG | 145,520,000 | $121.8 million |
| 54 | NATERA INC | COM · 632307104 | LONG | 982,241 | $54.5 million |
| 55 | NEOGENOMICS INC | NOTE 0.250% 1/1 · 64049MAB6 | LONG | 48,678,000 | $36.0 million |
| 56 | NEOGENOMICS INC | NOTE 1.250% 5/0 · 64049MAA8 | LONG | 33,000,000 | $31.0 million |
| 57 | NEUROCRINE BIOSCIENCES INC | COM · 64125C109 | LONG | 766,800 | $77.6 million |
| 58 | NEVRO CORP | COM · 64157F103 | LONG | 1,632,915 | $59.0 million |
| 59 | NEVRO CORP | NOTE 2.750% 4/0 · 64157FAC7 | LONG | 109,251,000 | $102.7 million |
| 60 | NOVOCURE LTD | NOTE 11/0 · 67011XAB9 | LONG | 134,334,000 | $116.8 million |
| 61 | NUVASIVE INC | NOTE 0.375% 3/1 · 670704AJ4 | LONG | 36,665,000 | $32.5 million |
| 62 | NUVASIVE INC | NOTE 1.000% 6/0 · 670704AL9 | LONG | 51,500,000 | $51.1 million |
| 63 | NUVATION BIO INC | COM CL A · 67080N101 | LONG | 4,122,900 | $6.8 million |
| 64 | ORTHOPEDIATRICS CORP | COM · 68752L100 | LONG | 998,871 | $44.2 million |
| 65 | OUTSET MED INC | COM · 690145107 | LONG | 1,754,350 | $32.3 million |
| 66 | PACIFIC BIOSCIENCES CALIF IN | COM · 69404D108 | LONG | 1,097,300 | $12.7 million |
| 67 | PARAGON 28 INC | COM · 69913P105 | LONG | 1,098,722 | $18.8 million |
| 68 | PENUMBRA INC | COM · 70975L107 | LONG | 107,044 | $29.8 million |
| 69 | PULMONX CORP | COM · 745848101 | LONG | 1,163,294 | $13.0 million |
| 70 | REPLIMUNE GROUP INC | COM · 76029N106 | LONG | 73,665 | $1.3 million |
| 71 | SILK RD MED INC | COM · 82710M100 | LONG | 63,331 | $2.5 million |
| 72 | STERIS PLC | SHS USD · G8473T100 | LONG | 95,694 | $18.3 million |
| 73 | SUPERNUS PHARMACEUTICALS | NOTE 0.625% 4/0 · 868459AD0 | LONG | 6,500,000 | $6.5 million |
| 74 | SYNDAX PHARMACEUTICALS INC | COM · 87164F105 | LONG | 920,049 | $19.4 million |
| 75 | TERNS PHARMACEUTICALS INC | COM · 880881107 | LONG | 1,997,055 | $23.6 million |
| 76 | TRANSMEDICS GROUP INC | COM · 89377M109 | LONG | 98,459 | $7.5 million |
| 77 | TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 · 89422GAA5 | LONG | 28,350,000 | $27.9 million |
| 78 | TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 · 761299AB2 | LONG | 56,031,000 | $53.9 million |
| 79 | VAXCYTE INC | COM · 92243G108 | LONG | 1,319,978 | $49.5 million |
| 80 | VIR BIOTECHNOLOGY INC | COM · 92764N102 | LONG | 604,036 | $14.1 million |
| 81 | XENON PHARMACEUTICALS INC | COM · 98420N105 | LONG | 2,137,110 | $76.5 million |